Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.
Alzheimer's disease (AD) and related dementias are a major public health challenge and present a therapeutic imperative for which we need additional insight into molecular pathogenesis. We performed a genome-wide association study and analysis of known genetic risk loci for AD dementia using ne...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16fab959c9274eda9e554f003340125a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:16fab959c9274eda9e554f003340125a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:16fab959c9274eda9e554f003340125a2021-11-25T05:51:36ZGenome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.1553-73901553-740410.1371/journal.pgen.1004606https://doaj.org/article/16fab959c9274eda9e554f003340125a2014-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25188341/?tool=EBIhttps://doaj.org/toc/1553-7390https://doaj.org/toc/1553-7404Alzheimer's disease (AD) and related dementias are a major public health challenge and present a therapeutic imperative for which we need additional insight into molecular pathogenesis. We performed a genome-wide association study and analysis of known genetic risk loci for AD dementia using neuropathologic data from 4,914 brain autopsies. Neuropathologic data were used to define clinico-pathologic AD dementia or controls, assess core neuropathologic features of AD (neuritic plaques, NPs; neurofibrillary tangles, NFTs), and evaluate commonly co-morbid neuropathologic changes: cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), hippocampal sclerosis of the elderly (HS), and vascular brain injury (VBI). Genome-wide significance was observed for clinico-pathologic AD dementia, NPs, NFTs, CAA, and LBD with a number of variants in and around the apolipoprotein E gene (APOE). GalNAc transferase 7 (GALNT7), ATP-Binding Cassette, Sub-Family G (WHITE), Member 1 (ABCG1), and an intergenic region on chromosome 9 were associated with NP score; and Potassium Large Conductance Calcium-Activated Channel, Subfamily M, Beta Member 2 (KCNMB2) was strongly associated with HS. Twelve of the 21 non-APOE genetic risk loci for clinically-defined AD dementia were confirmed in our clinico-pathologic sample: CR1, BIN1, CLU, MS4A6A, PICALM, ABCA7, CD33, PTK2B, SORL1, MEF2C, ZCWPW1, and CASS4 with 9 of these 12 loci showing larger odds ratio in the clinico-pathologic sample. Correlation of effect sizes for risk of AD dementia with effect size for NFTs or NPs showed positive correlation, while those for risk of VBI showed a moderate negative correlation. The other co-morbid neuropathologic features showed only nominal association with the known AD loci. Our results discovered new genetic associations with specific neuropathologic features and aligned known genetic risk for AD dementia with specific neuropathologic changes in the largest brain autopsy study of AD and related dementias.Gary W BeechamKara HamiltonAdam C NajEden R MartinMatt HuentelmanAmanda J MyersJason J CorneveauxJohn HardyJean-Paul VonsattelSteven G YounkinDavid A BennettPhilip L De JagerEric B LarsonPaul K CraneM Ilyas KambohJulia K KoflerDeborah C MashLinda DuqueJohn R GilbertHarry GwirtsmanJoseph D BuxbaumPatricia KramerDennis W DicksonLindsay A FarrerMatthew P FroschBernardino GhettiJonathan L HainesBradley T HymanWalter A KukullRichard P MayeuxMargaret A Pericak-VanceJulie A SchneiderJohn Q TrojanowskiEric M ReimanAlzheimer's Disease Genetics Consortium (ADGC)Gerard D SchellenbergThomas J MontinePublic Library of Science (PLoS)articleGeneticsQH426-470ENPLoS Genetics, Vol 10, Iss 9, p e1004606 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Genetics QH426-470 |
spellingShingle |
Genetics QH426-470 Gary W Beecham Kara Hamilton Adam C Naj Eden R Martin Matt Huentelman Amanda J Myers Jason J Corneveaux John Hardy Jean-Paul Vonsattel Steven G Younkin David A Bennett Philip L De Jager Eric B Larson Paul K Crane M Ilyas Kamboh Julia K Kofler Deborah C Mash Linda Duque John R Gilbert Harry Gwirtsman Joseph D Buxbaum Patricia Kramer Dennis W Dickson Lindsay A Farrer Matthew P Frosch Bernardino Ghetti Jonathan L Haines Bradley T Hyman Walter A Kukull Richard P Mayeux Margaret A Pericak-Vance Julie A Schneider John Q Trojanowski Eric M Reiman Alzheimer's Disease Genetics Consortium (ADGC) Gerard D Schellenberg Thomas J Montine Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
description |
Alzheimer's disease (AD) and related dementias are a major public health challenge and present a therapeutic imperative for which we need additional insight into molecular pathogenesis. We performed a genome-wide association study and analysis of known genetic risk loci for AD dementia using neuropathologic data from 4,914 brain autopsies. Neuropathologic data were used to define clinico-pathologic AD dementia or controls, assess core neuropathologic features of AD (neuritic plaques, NPs; neurofibrillary tangles, NFTs), and evaluate commonly co-morbid neuropathologic changes: cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), hippocampal sclerosis of the elderly (HS), and vascular brain injury (VBI). Genome-wide significance was observed for clinico-pathologic AD dementia, NPs, NFTs, CAA, and LBD with a number of variants in and around the apolipoprotein E gene (APOE). GalNAc transferase 7 (GALNT7), ATP-Binding Cassette, Sub-Family G (WHITE), Member 1 (ABCG1), and an intergenic region on chromosome 9 were associated with NP score; and Potassium Large Conductance Calcium-Activated Channel, Subfamily M, Beta Member 2 (KCNMB2) was strongly associated with HS. Twelve of the 21 non-APOE genetic risk loci for clinically-defined AD dementia were confirmed in our clinico-pathologic sample: CR1, BIN1, CLU, MS4A6A, PICALM, ABCA7, CD33, PTK2B, SORL1, MEF2C, ZCWPW1, and CASS4 with 9 of these 12 loci showing larger odds ratio in the clinico-pathologic sample. Correlation of effect sizes for risk of AD dementia with effect size for NFTs or NPs showed positive correlation, while those for risk of VBI showed a moderate negative correlation. The other co-morbid neuropathologic features showed only nominal association with the known AD loci. Our results discovered new genetic associations with specific neuropathologic features and aligned known genetic risk for AD dementia with specific neuropathologic changes in the largest brain autopsy study of AD and related dementias. |
format |
article |
author |
Gary W Beecham Kara Hamilton Adam C Naj Eden R Martin Matt Huentelman Amanda J Myers Jason J Corneveaux John Hardy Jean-Paul Vonsattel Steven G Younkin David A Bennett Philip L De Jager Eric B Larson Paul K Crane M Ilyas Kamboh Julia K Kofler Deborah C Mash Linda Duque John R Gilbert Harry Gwirtsman Joseph D Buxbaum Patricia Kramer Dennis W Dickson Lindsay A Farrer Matthew P Frosch Bernardino Ghetti Jonathan L Haines Bradley T Hyman Walter A Kukull Richard P Mayeux Margaret A Pericak-Vance Julie A Schneider John Q Trojanowski Eric M Reiman Alzheimer's Disease Genetics Consortium (ADGC) Gerard D Schellenberg Thomas J Montine |
author_facet |
Gary W Beecham Kara Hamilton Adam C Naj Eden R Martin Matt Huentelman Amanda J Myers Jason J Corneveaux John Hardy Jean-Paul Vonsattel Steven G Younkin David A Bennett Philip L De Jager Eric B Larson Paul K Crane M Ilyas Kamboh Julia K Kofler Deborah C Mash Linda Duque John R Gilbert Harry Gwirtsman Joseph D Buxbaum Patricia Kramer Dennis W Dickson Lindsay A Farrer Matthew P Frosch Bernardino Ghetti Jonathan L Haines Bradley T Hyman Walter A Kukull Richard P Mayeux Margaret A Pericak-Vance Julie A Schneider John Q Trojanowski Eric M Reiman Alzheimer's Disease Genetics Consortium (ADGC) Gerard D Schellenberg Thomas J Montine |
author_sort |
Gary W Beecham |
title |
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
title_short |
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
title_full |
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
title_fullStr |
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
title_full_unstemmed |
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. |
title_sort |
genome-wide association meta-analysis of neuropathologic features of alzheimer's disease and related dementias. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/16fab959c9274eda9e554f003340125a |
work_keys_str_mv |
AT garywbeecham genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT karahamilton genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT adamcnaj genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT edenrmartin genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT matthuentelman genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT amandajmyers genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT jasonjcorneveaux genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT johnhardy genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT jeanpaulvonsattel genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT stevengyounkin genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT davidabennett genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT philipldejager genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT ericblarson genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT paulkcrane genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT milyaskamboh genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT juliakkofler genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT deborahcmash genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT lindaduque genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT johnrgilbert genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT harrygwirtsman genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT josephdbuxbaum genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT patriciakramer genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT denniswdickson genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT lindsayafarrer genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT matthewpfrosch genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT bernardinoghetti genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT jonathanlhaines genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT bradleythyman genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT walterakukull genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT richardpmayeux genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT margaretapericakvance genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT julieaschneider genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT johnqtrojanowski genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT ericmreiman genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT alzheimersdiseasegeneticsconsortiumadgc genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT gerarddschellenberg genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias AT thomasjmontine genomewideassociationmetaanalysisofneuropathologicfeaturesofalzheimersdiseaseandrelateddementias |
_version_ |
1718414383883747328 |